Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes

Background: Obesity and type 2 diabetes mellitus (T2DM) are often accompanied with a disrupted diurnal rhythm of eating and sustained anabolic state, leading to metabolic inflexibility. In the present study, we plan to investigate effects of a sodium glucose co-transporter 2 (SGLT2) inhibitor, canag...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Kento Hara, Yusuke Sakai, Yuji Tajiri, Masatoshi Nomura
Format: Artykuł
Język:English
Wydane: Elsevier 2022-10-01
Seria:Heliyon
Hasła przedmiotowe:
Obesity
Type 2 diabetes mellitus
Metabolic inflexibility
SGLT2 inhibitor
Fat oxidation
Dostęp online:http://www.sciencedirect.com/science/article/pii/S2405844022023003

Internet

http://www.sciencedirect.com/science/article/pii/S2405844022023003

Podobne zapisy